Models of osteoarthritis: relevance and new insights by Staines, Katherine Ann et al.
Vol.:(0123456789) 
Calcified Tissue International 
https://doi.org/10.1007/s00223-020-00670-x
REVIEW
Models of Osteoarthritis: Relevance and New Insights
Hasmik Jasmine Samvelyan1 · David Hughes1 · Craig Stevens1 · Katherine Ann Staines1 
Received: 6 November 2019 / Accepted: 5 February 2020 
© The Author(s) 2020
Abstract
Osteoarthritis (OA) is a progressive and disabling musculoskeletal disease affecting millions of people and resulting in major 
healthcare costs worldwide. It is the most common form of arthritis, characterised by degradation of the articular cartilage, 
formation of osteophytes, subchondral sclerosis, synovial inflammation and ultimate loss of joint function. Understanding 
the pathogenesis of OA and its multifactorial aetiology will lead to the development of effective treatments, which are cur-
rently lacking. Two-dimensional (2D) in vitro tissue models of OA allow affordable, high-throughput analysis and stringent 
control over specific variables. However, they are linear in fashion and are not representative of physiological conditions. 
Recent in vitro studies have adopted three-dimensional (3D) tissue models of OA, which retain the advantages of 2D models 
and are able to mimic physiological conditions, thereby allowing investigation of additional variables including interac-
tions between the cells and their surrounding extracellular matrix. Numerous spontaneous and induced animal models are 
used to reproduce the onset and monitor the progression of OA based on the aetiology under investigation. This therefore 
allows elucidation of the pathogenesis of OA and will ultimately enable the development of novel and specific therapeutic 
interventions. This review summarises the current understanding of in vitro and in vivo OA models in the context of disease 
pathophysiology, classification and relevance, thus providing new insights and directions for OA research.
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Introduction
Osteoarthritis (OA), a common, chronic joint disorder, is a 
leading cause of disability and healthcare costs worldwide. 
The prevalence of OA varies depending on age, gender, race 
and geographical location. It is estimated that worldwide 
10% of men and 18% of women aged over 60 years have 
symptomatic OA [1]. OA affects over 8 million people in 
the UK alone [2] and, therefore, the predicted increase in 
the ageing population will only result in a greater occurrence 
of the disease.
OA is a complex degenerative disease for which the cel-
lular and molecular mechanisms of initiation and progres-
sion are incompletely understood. OA results in the progres-
sive loss of articular cartilage (AC) and thickening of the 
underlying subchondral bone (SCB), and is perpetuated by 
abnormal cartilage restoration and bone remodelling [3]. As 
OA progresses, the condition is characterised by joint space 
narrowing [4], as well as the formation of bone marrow 
lesions, cysts [5] and tidemark duplication [6]. Addition-
ally, the calcified cartilage region is found to increase in vol-
ume and is subject to vascular penetration which eventually 
reaches the non-calcified AC. Outside of the osteochondral 
tissues, the synovium surrounding these tissues is frequently 
inflamed, undergoing fibrosis and vascularisation [7]. OA 
clinical symptoms present as pain, stiffness, swelling and a 
decreased range of motion [8]. Various risk factors exist for 
OA including age, obesity, and physical trauma [9], as well 
as genetic predisposition [10]. At present, there is a paucity 
of non-invasive therapies available to patients and, therefore, 
there is a pressing need to develop novel targeted and effec-
tive disease-modifying treatments.
The diversity of risk factors that influence the AC and 
SCB in OA, together with the poor transition from in vitro 
to in vivo studies necessitates a validated in vitro model 
to investigate disease pathology [11]. Typically, in vitro 
cell models are two-dimensional (2D) and do not faithfully 
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model physiological conditions, producing a limited extra-
cellular matrix (ECM)-like environment that results in 
altered cell morphology [12]. Novel three-dimensional 
(3D) models of OA retain the benefits of 2D models whilst 
additionally providing a customisable environment which 
is more comparable to physiological conditions [13, 14]. 
Thus, 3D models allow the analysis of cell–cell interactions, 
cell-ECM interactions and cellular responses to pathologi-
cal stimuli.
Several animal models have been developed to study the 
pathogenesis of OA and the efficacy of new diagnostic tools 
and therapeutic interventions. However, due to the hetero-
geneity of the disease there is no single animal model that 
reflects the onset and progression of OA in humans [15]. 
Whilst there are similarities in the disease process between 
humans and animals, no single animal model is sufficient to 
study all the degenerative features of OA, thus model selec-
tion is based on the aetiology under investigation and the 
intended purpose. This review summarises the benefits and 
the limitations of current 2D and 3D in vitro models, and 
the classification and relevance of in vivo models to human 
pathogenesis, thereby providing future directions into OA 
research.
In Vitro Models of OA
A variety of in vitro models have been used to study the 
pathogenesis of OA at both tissue and cellular levels; how-
ever, no single model has proven to be the gold standard for 
OA research [16]. To date, publications using 2D cell culture 
primarily consider the chondrocyte as the “model” for OA, 
with little consideration of the role of other cells relevant to 
the articular joint such as SCB osteoblasts and osteocytes 
[17]. Therefore, to create a robust and reliable model of OA, 
the variety of articular joint tissues must be considered and 
investigated as a biological unit. Furthermore, in vitro and 
in vivo models often produce conflicting results. Thus, there 
is a need for an in vitro model that generates results consist-
ent with in vivo studies, and that overcomes the limitations 
of the current 2D and 3D models. Below, we have summa-
rised in vitro models currently used for the investigation of 
OA (Table 1).
2D Cell Models
Monolayer
2D monolayer models are inexpensive, permit the use of a 
single source of cells for multiple experimental treatments, 
and allow for rigorously controlled investigational condi-
tions (Table 1). Typically, 2D monolayer models involve the 
culturing of either primary cells or immortalised cell lines Ta
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on a flat surface in polystyrene culture flasks, which exposes 
the cultured cells to an equal volume of the surrounding 
media containing the various nutrients and growth factors 
essential for cell development and proliferation [18, 19]. 
2D in vitro models have routinely allowed for the screening 
of chondroprotective compounds to attenuate the catabolic 
factors involved in AC degradation. Usage of primary cells 
including osteoblasts and chondrocytes in 2D models pro-
vides a system that is associated with higher secretion of 
ECM and a phenotype more akin that found in vivo for the 
respective cell lineage. However, it is of note that primary 
cell culture is substantially more expensive than the use of 
cell lines, with primary cell source material being difficult 
to obtain and limited in terms of how often they can be sub-
cultured before they undergo de-differentiation and lose 
their distinct phenotype. The usage of cell lines provides 
a much less limited source of cell material however due to 
their immortalised nature, these cells have evaded cellular 
senescence and are associated with alterations in expres-
sion of markers typically associated with their non-immor-
talised counterpart. This can be exemplified by immortal-
ised chondrocytes which display a marked reduction in the 
secretion of ECM components compared to primary cells, 
thus reducing their reliability as true cell models. 2D in vitro 
models have routinely used for cytokine stimulation such as 
IL-1β to induce an OA phenotype which has allowed for the 
screening of chondroprotective compounds to attenuate the 
catabolic factors involved in AC degradation (e.g. IL-1β, 
TNF-α NO,  PGE2, COX-2, MMP3, MMP13, ADAMTS-4 
and ADAMTS-5) [12, 20–24]. Manipulation of 2D culture 
can also allow for investigation of individual signalling path-
ways. For example, recent interrogation of the Wnt/β-catenin 
signalling pathway with a novel inhibitor highlighted the 
critical role of the Wnt/β-catenin pathway in chondrogen-
esis and chondroprotection [25]. Additionally, monolayer 
cultures are easily transfected to manipulate gene and protein 
expression. For example, a proteomics study conducted on 
IL-1β/TNF-α stimulated human primary chondrocytes that 
were transfected with microRNAs (miRNA) identified pro-
teins of the complement cascade, mediators of the NF-κB 
pathway and several regulators of autophagy that may be 
important in the pathology of OA [26].
Despite the benefits of 2D cell culture, there are numer-
ous drawbacks that are inherent in the nature of the system 
itself (Table 1). When using primary cells in 2D culture 
such as primary chondrocytes, little consideration is given 
as to the location from which these cells are derived, be 
it from articular, costal or fibrillar cartilage, or a specific 
layer of the cartilaginous matrix. Notably, 2D cell culture 
results in altered cell morphology as cells are forced to 
grow in a planar environment where nutrient and oxygen 
gradients are non-existent [27]. This can result in cellular 
polarisation due to limited connections with surrounding 
cells. Polarisation is known to alter cell mechanotransduc-
tion; directly impacting cell signalling and, therefore the 
phenotype of the cell [28]. Chondrocyte cultures are no 
exception to this as they have been found previously to de-
differentiate and adopt an elongated fibroblast-like shape 
that has been associated with an altered genetic profile, 
including a reduction in the expression of aggrecan and 
other matrix specific genes [29]. Additionally, prolonged 
monolayer culture of chondrocytes results in the increased 
expression of Col1a1 mRNA, thus, signifying de-differ-
entiation [30]. Furthermore, incongruous results are often 
found between in vivo and in vitro studies. Also, there is 
a lack of support for investigation into mechanosensory 
stimulation in monolayer cell culture systems, which is 
also limited in its use in investigating cell–cell interactions 
and cell-ECM interactions. Therefore, to create a robust 
and reliable model of OA, the variety of articular joint 
tissues must be considered as a biological unit.
2D Co‑culture
2D co-culture models allow the investigation of cell–cell 
interactions in a shared environment. Like monolayer 
models, these can be used to investigate multiple experi-
mental treatments at once and have the potential to gener-
ate extensive data on pathological mechanisms (Table 1). 
Transwell plate models may be used which involves seed-
ing cells in the lower chamber of multi-well plates, with 
additional cells being seeded in transwell plates suspended 
above each well. This allows for investigation of cell–cell 
communication via the secretion of soluble factors into 
the surrounding media [31, 32]. Using this method, it has 
been shown that when chondrocytes and synoviocytes 
are co-cultured alongside adipose-derived mesenchymal 
stem cells, their expression of pro-inflammatory cytokines 
including IL-1β, IL-6, IL-8 and TNF-α significantly 
decreases [31]. A similar method revealed that chondro-
cytes cultured in the presence of adipose-derived stem 
cells have higher viability following TNF-α challenge, 
thus highlighting a paracrine chondroprotective role for 
adipose-derived stem cells [32]. As detailed, these experi-
ments allow for the exploration of a variety of factors on 
OA development. However, it should be noted that many 
of the limitations associated with 2D monolayer culture 
also exist in 2D co-culture, including altered cell mor-
phology and an inability to investigate direct cell–cell or 
cell-ECM contact.
3D Cell Models
Due to the limitations of 2D cell models, development 
of a more robust and reliable in vitro culture system to 
 H. J. Samvelyan et al.
1 3
investigate OA is required. Specifically, a model is required 
that is reproducible, financially viable, and that allows the 
investigation of cell–cell and cell-ECM interactions in dis-
ease pathology, as OA should be considered a disease of the 
whole joint as opposed to one particular aberrant cell type. 
3D cell models may therefore present a good alternative to 
2D culture. 3D models for the in vitro analysis of SCB and 
AC currently exist in a variety of forms, including explants 
and scaffold-based or scaffold-free systems, each with their 
own advantages and disadvantages (Table 1). However, a 
common feature of these 3D models that makes them suit-
able for a variety of applications is their ability to maintain 
the phenotype of cells such as AC chondrocytes.
Explants
Explant models are derived directly from in vivo tissue and 
maintain cells in their 3D surroundings, and both animal 
(e.g. murine femoral heads) and human (e.g. AC, or whole 
osteochondral plugs) explant systems are used within the OA 
field. These models still allow for the experimental manipu-
lation provided by in vitro culture, with experimental evi-
dence suggesting tissue viability is maintained [33]. Explant 
models have certain benefits such as enabling the investiga-
tion of compressive overload on AC, providing insight into 
the impact of cartilage loading in disease progression; a facet 
of OA that cannot be investigated by monolayer models [34]. 
Comparable to monolayer culture, explants may undergo 
multiple treatments in vitro allowing for the investigation 
of a variety of factors in a controlled environment. Unlike 
monolayer culture, osteochondral explant models may be 
more readily used to investigate the relationship between 
AC and the underlying SCB tissue. Osteochondral explants 
challenged with IL-1β have been found to express a sig-
nificantly lower level of MMP13 than cartilage explants 
alone; results from this study also indicate that osteochon-
dral explant expression of alkaline phosphatase may differ 
from chondrocyte explants [34]. Additionally, cartilage 
explants challenged with IL-1β produced an elevated level 
of TNF-α compared to controls, whereas osteochondral 
explant TNF-α secretion was unchanged, suggesting the 
presence of bone or synovium may reduce TNF-α expres-
sion and highlighting the need to consider all joint tissues 
in the analysis of OA pathophysiology [35]. In agreement, 
bone explants have been found to secrete increased levels 
of pro-Col-I, IL-6 and MCP-1 compared to osteochondral 
explants when challenged with lipopolysaccharide, suggest-
ing that different cells within the osteochondral tissues can 
attenuate one another [33]. Furthermore, Haltmayer et al. 
[36] detailed a co-culture model in which horse osteochon-
dral plugs and synovium membrane explants were cultured 
in vitro and stimulated using IL-1β and TNF-α. This study 
showed that the osteochondral-synovium co-culture enabled 
upregulation of MMP1 expression, subsequently attenuating 
genetic expression of MMP3, MMP13, IL-6 expression, as 
well as increasing genetic expression of ECM products such 
as collagen type II.
Clearly, explant models provide benefits over monolayer 
culture, particularly regarding interactions between tissues; 
however, there are still shortcomings that must be addressed 
when using these models. For example, cells at the surgical 
edge may die when tissue is removed from specimens, and 
tissue from any single same biological source is finite; with 
different sources potentially eliciting different responses 
[35]. Importantly, explanted tissues are cultured in artifi-
cial settings which limit investigation of mechanical load-
ing effects or angiogenic effects following surgical resection 
[33]. Additionally, cells derived from explant outgrowths 
are susceptible to the de-differentiation and morphology 
changes observed over time in 2D culture, and there is still 
a requirement for use of culture media which may contain 
components that have undesirable effects on the tissues [33].
Scaffold‑Based Systems
3D tissue scaffolds provide a platform in which biochemis-
try, matrix elasticity and micro-architecture can be altered 
[37]; this is important as polarity, pore size and pore inter-
connectivity affect cell fate and the ability of cells to secrete 
ECM products. Additionally, biologic hydrogels have the 
ability to support chondrocyte proliferation and ECM pro-
duction, as well as osteoblast growth and mineralisation, 
providing a potential model for investigating activity at the 
osteochondral interface [37–39].
Biologic hydrogels represent a scaffold-based system 
that are derived from natural resources, have a large water 
component and are used due to their similarities to ECM 
modifiability, bioactivity, biodegradability, porosity, bio-
compatibility and low immunogenicity. Biologic hydrogels 
derived from materials such as alginate, gelatin, chitosan 
and hyaluronan promote chondrocyte viability and prolifera-
tion, as well as collagen type II, aggrecan and Sox9 expres-
sion, markers which normally diminish in monolayer culture 
[40–42]. Additionally, biologic hydrogels have the ability 
to support chondrocyte proliferation and ECM production, 
as well as osteoblast growth and mineralisation, providing 
a potential model for investigating activity at the osteo-
chondral interface an area important in OA pathology [43]. 
Remarkably, certain biologic hydrogels can be manufactured 
through 3D printing, increasing availability and reducing 
the need for fabrication and crosslinking with potentially 
toxic reagents and hazardous processes [44]. Recent work 
on developing an in vitro 3D model of OA by Galuzzi et al. 
[45] has shown that nasal chondrocytes encapsulated within 
alginate beads are able to produce increasing levels of Gly-
cosaminoglycans (GAG); however, culture in these beads 
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had no effect on AC chondrocyte GAG secretion, highlight-
ing a potential limitation for their use as a model of OA. 
Unfortunately, biologic hydrogels can suffer from variation 
in batch to batch manufacturing, as with explants, single 
biological sources can vary which can impact the proper-
ties of the gel. These must be considered when choosing a 
biologic hydrogel culture system.
Synthetic hydrogels are prevalent in 3D tissue culture, 
and like biological hydrogels they possess desirable features 
for tissue culture [46, 47]. Importantly, synthetic hydrogels 
do not originate from a finite source meaning variability 
between manufactured products is reduced [48]. Synthetic 
hydrogels have been shown to facilitate chondrogenesis and 
increased expression of key chondrocytic markers such as 
collagen type II, and non-collagenous proteins such as osteo-
calcin, compared to 2D controls [49, 50]. Synthetic hydro-
gels can also be finely tuned via chemical modification, 
such as the inclusion of chondrogenic molecules which are 
delivered to hydrogel embedded cells such as biotinylated 
TGF-β3 which promotes chondrogenesis, as well as collagen 
type II and GAG expression [51]. Stüdle et al. describe a 
model in which bone marrow stem cells (BMSCs) seeded 
in Poly (ethylene glycol) (PEG) hydrogels are layered with 
non-functionalised PEG-seeded nasal chondrocytes. This 3D 
construct results in a calcified bottom layer of BMSCs and a 
cartilaginous top layer of chondrocytes producing a 3D co-
culture model interface of SCB and AC-like tissues which 
could be adapted for investigation into OA pathology [51]. 
Similarly, a hydrogel co-culture system has been produced 
[52] using transwell plates to elucidate the relationship 
between chondrocytes and macrophages in OA. Research 
has also shown synthetic hydrogels such as those derived 
from PEG dimethacrylate are able to be integrated into a 
mechanical loading system which was able to direct human 
mesenchymal stem cell differentiation into AC, calcified 
cartilage and SCB tissues [47]. Preliminary data therefore 
supports the potential of a synthetic 3D hydrogel co-culture 
system that includes multiple cell types involved in OA to 
investigate cell–cell interactions at a molecular level in the 
context of OA development.
Hydrogels thus provide materials that have a variety of 
suitable characteristics for in vitro modelling; however, cer-
tain disadvantageous features exist. In vitro modelling must 
consider the composite parts of these hydrogels as they are 
comprised of materials that are dissimilar to those found 
in the natural ECM and therefore may alter cell behaviour. 
Moreover, these hydrogels contain a large water component, 
which has implications for the structural integrity of the gel 
as an anchoring substrate and while this may be suitable for 
mimicking certain in vivo environments such as AC, it may 
be unsuitable for others such as SCB which has very little 
ECM water content in vivo.
Pre-fabricated scaffold, comprised of biodegradable 
polymers, are favoured for their biocompatibility, allow-
ing for easy integration into biological systems as exempli-
fied using PCL [poly(ɛ-caprolactone)] in surgical sutures 
and implants. Pre-fabricated scaffolds also possess a low 
melting point, providing desirable thermoplastic properties 
which facilitate 3D printing. Additionally, the viscoelastic 
properties of these scaffolds provide benefits for cell culture 
as substrate stiffness can determine cell growth [53, 54]. 
However, it has been noted that polymers such as PCL are 
non-osteoinductive and therefore their use in the culture of 
bone tissues is considered limited, limiting their potential 
to be used to investigate an osteoblastic OA phenotype [55]. 
To remedy this, recent research has taken to altering PCL 
scaffold biochemistry and fabrication methods. Indeed, oste-
oinductive and mechanically supportive molecules such as 
hydroxyapatite (HPA) and Poly(propylene fumarate) (PPF) 
have been included to facilitate bone growth [38]. PCL/HPA/
PPF scaffolds were found to boost BMSC osteoinduction 
increasing levels of calcium deposition and Runx2 expres-
sion, a marker of osteoblast differentiation, and were par-
ticularly noncytotoxic [38]. In consideration of improving 
manufacturing methods, Brennan et al. [56] developed a 
novel jet-spraying technique as an alternative to the commer-
cially accepted electrospinning technique. Electrospinning 
produces nanofibre scaffolds that closely resemble the native 
bone ECM; however, cell infiltration is a common problem 
with these scaffolds. Jet-spraying manufacturing produced 
scaffolds that boost alkaline phosphatase levels and calcium 
deposition whilst maintaining collagen production at similar 
levels to commercially available electrospun scaffolds – this 
is due to jet-spraying producing scaffolds with smaller pore 
diameters and a greater variety of fibre thickness within the 
scaffold. Notably, these scaffolds resulted in higher osteo-
genesis than their 2D counterparts [56].
Pre-fabricated scaffolds also include microcarriers which 
do not possess the mesh-like physical properties expected of 
a scaffold, but instead anchor cells on their surface providing 
3D support [57]. Thus far, microcarriers have shown desir-
able chondrogenic qualities. Galuzzi et al. [45] described the 
development of a silk/alginate microcarrier model in which 
silk anchors human nasal chondrocytes to the surface of the 
silk/alginate manufactured beads avoiding encapsulation and 
negating issues associated with cell infiltration. These cells 
retained a chondrocytic phenotype via expression of mark-
ers such as collagen type II and were metabolically active 
even after cryopreservation [45]. Microcarriers have also 
been shown to support biochemical modification [58]. A 
microcarrier consisting of PGLA (poly(d,l-lactide–co-gly-
colide acid) coated with fibronectin and poly-d-Lysine to 
promote cell adhesion, and loaded with TGF-β was shown 
to upregulate chondrogenic markers, whilst downregulating 
osteogenic proteins [58]. This highlights the ability of 3D 
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culture models to be tailored to guide stem cells to a specific 
lineage giving more control over differentiation than can be 
found in 2D models.
By showing chondrogenic and osteogenic potential that 
can also facilitate cell–cell and cell-ECM interaction, scaf-
fold-based systems therefore offer great potential as in vitro 
systems to model OA. Notably, cell proliferation is typically 
found to be slower in scaffold-based systems [59], as is cell 
migration [60]. However, research involving these models 
is still in relative infancy compared to 2D in vitro models. 
Further work is needed to establish the implications of these 
characteristics on model development as well as the robust-
ness and reliability of these systems.
Scaffold‑Free Systems
Pellet culture provides an alternative to typical 3D culture 
that carries less of a financial burden than other 3D sys-
tems such as hydrogels and scaffolds. Typically, pellet cul-
ture involves maintaining centrifuged cell pellets in conical 
tubes, or multi-well plates, in such a manner that the cells 
are clumped together, adding a 3D aspect to the culture sys-
tem. De-differentiated human AC chondrocytes cultured as 
a pellet have shown increased expression of chondrogenic 
SOX9 as well as Col2a1 and aggrecan mRNAs [61]. Addi-
tionally, pellet cultured chondrocytes exhibit reduced expres-
sion of hypertrophy markers such as collagen type X, as well 
as a reduction in calcification markers such as Runx2 and 
alkaline phosphatase. Pellet culture also induces collagen 
type II expression to a higher level than both 3D alginate 
bead culture and monolayer culture; however, expression of 
collagen type X and Runx2 protein did not differ between 
monolayer, pellet or alginate bead culture [61].
In contrast to the benefits described, pellet culture has 
inherent systematic disadvantages that must be considered 
when using this in vitro culture method, particularly for OA. 
Cells cultured in a pellet show a large reduction in prolifera-
tive capacity, whilst cells in the centre of the pellet may be 
deprived of nutrients and oxygen; providing an environment 
for maintaining non-hypertrophic chondrocytes for in vitro 
analysis [62]. However, these conditions can cause apop-
tosis; and more recent research has provided an alternative 
chondrogenic model using transwell plates. Whilst these 
hypoxic and low nutrient conditions may be suitable for 
chondrogenesis, it has been shown that hypoxia can reduce 
osteogenesis [63]. If an in vitro model of OA is to be fully 
comprehensive, it must suitably support the variety of cell 
types that are found within an articular joint including chon-
drocytes and osteoblasts.
Hanging drop cell culture involves pelleting cells and 
culturing them in an inverted fashion against a 2D surface, 
allowing gravity to help maintain the cells in suspension 
reducing the chance of polarisation. In vitro culture using 
the hanging drop technique has been shown to promote an 
in vivo-like rounded morphology accompanied by increased 
levels of Sox9 mRNA compared to both monolayer and typi-
cal pellet culture method. Additionally, hanging drop culture 
has been shown to induce upregulation of proteoglycan 4 
(Prg4) mRNA and its associated protein lubricin—which is 
found in healthy AC joint space, providing lubrication [64]. 
Hanging drop models present similar advantages as pellet 
culture systems, but notably share the same disadvantages 
and therefore further research is required to determine their 
suitability as a potential adaptable model for the in vitro 
investigation into OA.
In Vivo Models of OA
Clinical and preclinical studies have proven to be indispen-
sable tools to study the pathogenesis and progression of OA. 
However, the chronic nature of the disease, variability in 
the onset of symptoms and rate of progression in humans 
present challenges for clinical studies [65]. Further, it is dif-
ficult to obtain human samples during early stages of disease 
because patients mainly present in the clinic after OA has 
developed. OA research currently relies on in vivo models 
in which disease susceptibility and progression can be eas-
ily defined, allowing identification of the aetiological fac-
tors that lead to OA. Thus the knowledge gained from these 
preclinical models could be essential in developing early 
therapeutic interventions.
At least 18 animal models have been developed to 
study pathophysiological features and pathogenesis of OA 
[66]. The advantages of smaller model organisms such as 
zebrafish, rodents (mice and rats), guinea pigs and rabbits 
include relatively low cost, ease of handling and mainte-
nance. As a result, they are often used as the first models 
for developing therapeutic interventions and initial drug-
screening studies [67, 68].
Large model organisms including dogs, goats, sheep and 
horses are used to study the pathological process of OA and 
develop more clinically relevant features due to their striking 
anatomic similarities to humans including joint size and AC 
thickness. Other advantages of large animal models include 
prevalence of naturally occurring primary and secondary 
OA, feasibility of arthroscopic intervention and diagnostic 
imaging such as MRI [69]. These models are required to test 
the efficacy of drugs prior to the clinical trials and approval 
of therapeutic interventions by the regulatory authorities 
[70]. The disadvantages of large animal models are mainly 
related to cost, handling challenges, longer time to age, 
slower progression to OA and ethical considerations [67].
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Based on the disease aetiology, OA can be classified 
into two main types: primary or idiopathic OA and second-
ary OA. Primary (idiopathic) OA is described as naturally 
occurring OA affecting one joint (localised) or three or more 
joints (generalised), whereas secondary OA is associated 
with a variety of causes and risk factors leading to disease 
including trauma, metabolic bone and congenital disorders 
[71]. Due to its heterogeneous nature, OA can be further cat-
egorised into clinical phenotypes including post-traumatic, 
metabolic, ageing, genetic and pain phenotypes [72]. Cur-
rent animal models for OA can also be broadly classified into 
these subtypes, and it is imperative that these classifications 
are considered at the time of model selection and subse-
quently when interpreting results (Table 2).
In Vivo Models of Primary OA
Spontaneous animal models of OA are commonly used to 
study primary OA and subcategorised into naturally occur-
ring and genetically modified models. These models exhibit 
slow progression of the disease which imitates natural pro-
gression of the human primary OA, and thus, are time-con-
suming but pathophysiologically are closely related to the 
human disease (Table 2) [15, 70].
Naturally Occurring Models
Naturally occurring models of OA include mice, certain 
strains of guinea pigs, rabbits, dogs and horses. Different 
mouse strains exhibit different OA vulnerability. Particular 
strains including STR/ort and C57BL/6 are considered pre-
disposed to developing spontaneous idiopathic OA. Other 
strains, notably the CBA mice are considered to have a 
resistance to the development of spontaneous OA and, there-
fore, the lack of overt OA makes them effective controls for 
these studies [73]. The STR/ort mouse is a well-recognised 
model of naturally occurring OA with disease pathology 
starting early in life and showing similar characteristics to 
human primary OA. The transgenic STR/ort mouse, directly 
derived from STR/1 N strain, has featured in over 80 studies 
of OA [74]. The first studies reported increasing incidence 
and severity of OA from 18 weeks of age and described a 
greater incidence of osteoarthritic knee, elbow, ankle and 
temporomandibular joint pathology, specifically in male 
mice [75, 76]. In STR/ort mice AC undergoes structural 
deterioration similar to human OA due to early changes in 
AC matrix integrity and composition [77], a transient chon-
drocyte phenotype and altered function [78], dysregulation 
of cell signalling pathways such as TGF-β and Wnt [79, 80] 
and increased oxidative stress [81].
The albino Dunkin-Hartley or Hartley guinea pigs are 
widely used to study naturally occurring OA, primarily due 
to the histopathological similarities to human primary OA 
and their rapidity of growth to skeletal maturity compared 
to other larger animal spontaneous models of OA [82, 83]. 
Other advantages include the size of the joints allowing suf-
ficient tissue and synovial fluid collection for relevant down-
stream analyses, and the ability to study joint inflammation, 
as well as ease of handling of the species [84]. Addition-
ally, the Hartley guinea pig is a useful model to study OA-
associated pain and evaluate feasibility of novel therapies, 
including nociception inhibitors, human mesenchymal stem 
cells, gene therapy and RNA interference [85–87].
Previous studies showed radiographic evidence of natu-
rally occurring OA in 50% of rabbits over 6 years of age 
and more than 70% of rabbits older than 9 years of age [88]. 
Rabbits are used for bioengineering experiments to develop 
treatments for diseased cartilage [89]. Dogs and horses are 
also beneficial as translational models of naturally occur-
ring OA for preclinical studies to develop novel and effec-
tive therapeutic interventions [90]. The front knee of the 
horse with two layers of carpal bones is analogous to the 
human wrist. The metacarpophalangeal and carpal joints 
of the horse exhibit close fitting of articular surfaces and 
are most susceptible to primary OA. The articular surfaces 
develop erosions and wear lines due to osteochondral defects 
and fragmentation in these joints. The SCB sclerosis and 
subsequent focal osteonecrosis occur as disease progresses 
[91, 92], thus, this model has been used to study AC repair, 
osteochondral defects and bone remodelling that leads to 
osteophyte formation.
Genetically Modified Models
Genetically modified models including knockout and knock-
in animal models are useful to determine the genetic factors 
involved in OA pathogenesis, including the function of spe-
cific genes associated with AC degradation, SCB remod-
elling and inflammation [69, 70]. Thus, specific genes or 
gene products involved in the protection of premature AC 
degradation can be exploited to develop disease-modifying 
treatments. The zebrafish model displays phenotypic char-
acteristics of OA including reduced joint mobility, loss of 
AC and formation of bony spurs. It has been used for func-
tional studies on OA susceptibility genes that play a role in 
disease [68]. The entire mouse genome has been sequenced; 
thus, it is relatively easy to produce genetically modified 
mouse models of OA and these have been used extensively 
to study genotype–phenotype relationships. These mice are 
compared to their wild-type counterparts to evaluate spon-
taneous development of the disease, or are used in combina-
tion with surgically or chemically induced models of OA, as 
discussed in the next section [93].
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In Vivo Models of Secondary OA
Secondary OA associated with injury, insult or trauma to the 
affected joint (post-traumatic OA) is the most widely studied 
subtype of OA [94]. Secondary OA is investigated by induc-
ing direct or indirect injuries to the joints, using invasive and 
non-invasive models of OA (Table 2).
Invasive Models
Invasive models are largely used to study the pathogenesis 
of post-traumatic OA and to assess the therapeutic efficacy 
of drugs/potential therapeutic agents for the disease. The 
advantages of invasive models include rapidly progress-
ing OA and, therefore shorter study timeframes, induction 
of severe lesions, reproducibility and relatively low cost 
compared to the spontaneous animal models. Nonetheless, 
these models are inappropriate for the pathogenetic studies 
of naturally occurring primary degenerative OA. Invasive 
models of OA include surgically induced and chemically 
induced models. Invasive surgical procedures induce OA 
by disrupting joint biomechanics, producing inflammation, 
instability and altering load-bearing of the joints, whereas 
relatively less invasive intra-articular injection of chemical 
agents and inflammatory compounds including monosodium 
iodoacetate (MIA), papain, quinolone and collagenase alter 
joint homeostasis and lead to the histological and morpho-
logical destructions of its structures [15].
Transection of the anterior cruciate ligament (ACL) is 
one of the most frequently used surgical methods for study-
ing OA in vivo. The ACL injury causes destabilisation of the 
joint, leading to post-traumatic OA and imitating AC deg-
radation. The slow development of OA lesions makes this 
surgical model advantageous for pharmaceutical studies. In 
mice and rats, transection of ACL is performed either alone 
or in combination with transection of the posterior cruciate 
ligament (PCL) or medial or/and lateral collateral ligaments, 
as well as meniscectomy. Such combinations allow research-
ers to study the grades and various stages of OA develop-
ment [95]. Animal models including goats, sheep and cows 
are used for transection of ACL due to the large size of their 
stifle and, therefore, easy replication of the surgical proce-
dure and anatomical similarities to the human knee [15].
Destabilization of the medial meniscus (DMM) is a 
well-established and widely used surgically induced model 
of OA. This model can be used for target validation stud-
ies using genetically modified animals and evaluation of 
the pathophysiological roles of various molecules and 
enzymes in OA in vivo. The DMM murine model involves 
sectioning of the medial meniscotibial ligament (MMTL), 
which anchors the medial meniscus to the tibial plateau, 
giving destabilisation of the medial meniscus. Following 
DMM, medial displacement of the medial meniscus in a 
mouse knee provides a smaller area to transmit the weight-
bearing forces and leads to an increased local mechanical 
stress [96]. DMM model induces OA with great ease, pro-
vides extremely good reproducibility and slow progression 
of the disease, thus resembling slowly progressive human 
OA and allowing evaluation of disease-modifying OA 
drugs. Most DMM studies are conducted on young adult 
animals; however, when DMM is performed on aged ani-
mals the ensuing OA is more severe due to the age-related 
changes in a basal pattern of gene expression in joint tis-
sues. Furthermore, induced OA may be more progressive 
in male than in female mice following DMM [97]. Thus, 
animal age and gender should be taken into consideration 
when modelling molecular mechanisms to define thera-
peutic targets for OA [98].
In mice, total medial meniscectomy in combination with 
transection of the medial cruciate ligament (MCL) engen-
ders osteoarthritic changes around 8 weeks after surgery. 
In rats, meniscectomy generates AC defects 1 week and 
changes in SCB 2 weeks after surgery. While in humans, 
surgical removal of a meniscus following knee injury rep-
resents a significant risk factor for radiographic OA after 
20 years [99]. This procedure can also be performed in 
rabbits, dogs, sheep and monkeys. The site for the surgery 
varies depending on the load-bearing capacity of each ani-
mal, either on its medial or lateral menisci. For instance, in 
rabbits, partial meniscectomy can be performed either on 
medial or lateral menisci, resulting in different outcomes. 
In contrast to humans and rodents, rabbits load the lateral 
compartment of the joint more than the medial one, thus 
partial lateral meniscectomy, compared with partial medial 
meniscectomy, results in more severe lesions and rapidly 
progressing OA [15].
Medial meniscal tear is achieved through transection of 
the MCL to expose the meniscus in the knee of an animal 
model. This surgical procedure induces rapidly progressing 
OA leading to AC degradation and joint instability similar 
to alterations and morphological lesions of tissues in human 
osteoarthritic joints upon medial meniscal tear [15].
Oestrogen deficiency in postmenopausal women has been 
related to osteoporosis and consequently increased risk of 
developing OA [100]. Thus, ovariectomised animal mod-
els can be used to study oestrogen deficiency as a potential 
cause of OA and determine the protective function of oes-
trogen. Mature ovariectomised rats develop osteoarthritic 
lesions of the stifle 9 weeks after surgery and have been 
shown to be the most representative models for the human 
postmenopausal OA [101]. Ovariectomised rabbits have 
been used to study direct effects of oestrogen insufficiency 
on OA development [102]. Other model organisms including 
mice, guinea pigs and sheep have also been used to deter-
mine the detrimental effect of oestrogen deficiency on the 
AC and discover new pathologic pathways. Nonetheless, the 
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precise pathophysiological mechanism of oestrogen action 
is yet to be elucidated [103].
Chemically induced models of OA eliminate the need for 
surgery and the possibility of associated infection in some 
models. They are easy to induce and reproduce, and are use-
ful for short-term studies. Administration of different dos-
ages and intervals of compounds allows the study of various 
stages of disease development. These models are primarily 
used to study OA pain-related behaviours and the effects 
of drugs on major hallmarks of OA; pain and inflamma-
tion [104]. For example, in rats’ intra-articular injection of 
MIA, a metabolic inhibitor of glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) activity of aerobic glycolysis path-
way in chondrocytes, induces chondrocyte death, leading to 
osteophyte formation and AC degradation, rapid inflamma-
tion, chronic pain, hyperalgesia and allodynia [105]. The 
MIA rat model resembles the histological and pain-related 
behaviour of human OA and can therefore be more predic-
tive of pain-alleviating drug efficacy in comparison to the 
other models used to test drugs for OA. However, due to 
rapid and widespread cell death and joint changes atypical 
to human primary or secondary OA pathophysiology, the 
validity of chemically induced models is questionable.
Non‑invasive Models
Numerous non-invasive models of secondary OA have been 
described within the last few years. Each model initiates 
joint degeneration and produces external trauma through 
mechanical impact. Non-invasive mouse models of post-
traumatic OA include fracture of the intra-articular tibial 
plateau, cyclic AC tibial compression and ACL rupture 
via tibial compression overload [106, 107]. These cause 
localised osteoarthritic joint injuries, which are not always 
achievable in the more invasive models, and thus allow rep-
lication of human post-traumatic OA caused by mechanical 
external injuries.
Fracture of the intra-articular tibial plateau is the earli-
est described non-invasive mouse model of secondary OA 
[108]. This injury model represents one of the high-energy 
impact injuries sustained in humans such as frontal motor 
vehicle collisions. In this model, the mouse knee joint was 
placed onto a triangular cradle of materials testing machine 
capable of delivering controlled loads and displacements. A 
wedge-shaped indenter mounted to the testing system was 
then used to apply compressive load to the tibia to induce 
articular fracture. Intra-articular tibial plateau fractures are 
one of the causes of post-traumatic OA in humans, therefore, 
this is an ideal model to study the pathological changes in 
the joints that occur after the acute injury.
The axial tibial loading model has been widely estab-
lished in rodents and used to investigate adaptive responses 
of cortical and trabecular bone to mechanical loading 
[109–113]. In a cyclic AC tibial compression model, the 
external non-invasive dynamic mechanical loading is 
applied to the mouse tibia through the knee and ankle joints. 
This modifies the AC structure through a mechanoadap-
tive homeostatic response and contributes to OA develop-
ment. One loading episode is sufficient to induce localised 
AC injury, whereas multiple loading episodes induce AC 
lesions resembling those observed in OA. The controlla-
bility of this model allows determination of the short- and 
long-term effects of single or multiple loading episodes on 
AC integrity [107]. Furthermore, intermittent non-invasive 
mechanical loading induced SCB thickening in these mice 
that may be intensified locally by adjacent AC lesions, thus 
indicating a spatial link between changes in SCB architec-
ture and AC lesions following a mechanical trauma [114].
Similarly, the tibial compression model has been devel-
oped for studies of post-traumatic OA to create an acute knee 
injury in animals by rupturing the ACL [106]. The injury 
pathology of this model closely replicates ACL injury in 
humans. Tibial compression with a high peak force over-
loading regimen was sufficient to induce ACL rupture in 
young 8-week-old C57BL/6 mice [115]. Ruptured ACL and 
lax fibre alignment in the ligament led to instability of the 
whole joint, increased joint gap and anterior translocation 
of the tibia in relation to femur. Due to the change of posi-
tion of bones in the knee joint the AC was no longer loaded 
in the same way as in the previously discussed cyclic tibial 
compression model, leading to the apoptosis of cells and 
eroded AC in multiple locations with degenerations often 
extending to SCB. The destabilisation of the joint upon 
ACL rupture, the increased concentration of inflammatory 
cytokines and hemarthrosis caused rapid synovial inflamma-
tion and synovial cell proliferation, leading to the formation 
of visible ectopic cartilaginous nodules (neocartilage meta-
plasia) 2 weeks post-injury [116]. Thus, this model is use-
ful for studies of early osteoarthritic changes and the acute 
processes initiated by ACL rupture. Further, this model can 
be used to study low energy sport injuries, as well as the 
effect of early treatments following acute injuries. The tibial 
compression overload model may not be useful for long-
term studies to determine the onset of OA due to severe 
osteophyte formation observed as part of the compensatory 
mechanism to joint instability.
Conclusion
This review provides an overview of the common in vitro 
and in vivo models currently being used to study the patho-
genesis of primary and secondary OA. 2D in vitro cell cul-
ture models offer numerous benefits and facilitate the elu-
cidation of the molecular mechanisms underlying disease 
pathology. 2D models are quick, easy to work with and are 
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financially viable; however, they have limitations includ-
ing chondrocyte de-differentiation, and a reduced capacity 
to investigate cell–cell and cell-ECM interactions. Current 
3D models provide a solution to some of these limitations; 
however, at present they lack biological complexity, and 
results generated do not often compliment results gener-
ated in animal models. There is therefore a pressing need 
for the development of novel, physiological, 3D cell culture 
models to provide alternatives to in vivo studies. The use 
of animal models is however an imperative stepping-stone 
for the preclinical discoveries, from fundamental to transla-
tional research. They are powerful research tools for study-
ing disease pathogenesis and for developing novel targeted 
therapeutic interventions for OA. To date, there is no single 
ideal experimental model that permits investigation of all 
features of OA, and consideration of the advantages and dis-
advantages of each model is instrumental when designing 
a study. Another important consideration is the 3Rs (reduc-
tion, refinement and replacement), the ethical framework 
for conducting scientific experiments involving animals, to 
ensure that studies are well-designed, controlled, powered, 
evaluated and reported. The continuing identification and 
development of suitable OA models are still needed and sub-
stantial work remains before the results from these models 
are truly translatable to the human condition.
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